Johnson & Johnson reported solid third-quarter results with sales and adjusted earnings exceeding expectations. The announcement of a $5 billion share repurchase program and managementâ€™s confident outlook despite inflation and currency headwinds are likely to boost investor sentiment in the short term.

[1]